Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ketamine | 6 | 2023 | 215 | 1.850 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 4 | 2023 | 116 | 1.230 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2023 | 71 | 1.020 |
Why?
|
| Depressive Disorder, Major | 3 | 2022 | 401 | 0.800 |
Why?
|
| Anxiety Disorders | 3 | 2023 | 685 | 0.640 |
Why?
|
| Hearing Disorders | 3 | 2023 | 27 | 0.640 |
Why?
|
| Neuroprotective Agents | 1 | 2020 | 157 | 0.640 |
Why?
|
| Anxiety | 1 | 2023 | 966 | 0.550 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2022 | 149 | 0.510 |
Why?
|
| Veterans | 1 | 2020 | 1752 | 0.320 |
Why?
|
| Depression | 4 | 2023 | 1248 | 0.270 |
Why?
|
| Antidepressive Agents | 3 | 2023 | 290 | 0.260 |
Why?
|
| Quality of Life | 3 | 2023 | 1954 | 0.240 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2023 | 13 | 0.210 |
Why?
|
| Electroencephalography | 3 | 2023 | 868 | 0.200 |
Why?
|
| Mood Disorders | 1 | 2023 | 127 | 0.190 |
Why?
|
| Osteoarthritis, Hip | 1 | 2022 | 52 | 0.190 |
Why?
|
| Suicide | 1 | 2023 | 177 | 0.180 |
Why?
|
| Kynurenic Acid | 1 | 2020 | 8 | 0.180 |
Why?
|
| Quinolinic Acid | 1 | 2020 | 10 | 0.180 |
Why?
|
| Parkinson Disease | 2 | 2018 | 693 | 0.180 |
Why?
|
| Kynurenine | 1 | 2020 | 21 | 0.180 |
Why?
|
| Emotions | 1 | 2023 | 365 | 0.180 |
Why?
|
| Family | 1 | 2023 | 567 | 0.170 |
Why?
|
| Humans | 19 | 2023 | 124405 | 0.170 |
Why?
|
| Treatment Outcome | 7 | 2023 | 12287 | 0.170 |
Why?
|
| Precision Medicine | 1 | 2023 | 315 | 0.170 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 312 | 0.160 |
Why?
|
| Osteoarthritis, Knee | 1 | 2022 | 244 | 0.160 |
Why?
|
| Brain | 3 | 2023 | 3003 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2019 | 101 | 0.150 |
Why?
|
| Hallucinations | 1 | 2018 | 26 | 0.150 |
Why?
|
| Occipital Lobe | 1 | 2018 | 32 | 0.150 |
Why?
|
| Lewy Body Disease | 1 | 2018 | 18 | 0.150 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2018 | 174 | 0.140 |
Why?
|
| Biomarkers | 2 | 2023 | 2980 | 0.140 |
Why?
|
| Infusions, Intravenous | 3 | 2022 | 548 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 630 | 0.110 |
Why?
|
| Adolescent | 4 | 2023 | 19358 | 0.110 |
Why?
|
| Female | 8 | 2023 | 66305 | 0.110 |
Why?
|
| Cognition | 1 | 2018 | 737 | 0.100 |
Why?
|
| Child | 5 | 2023 | 24527 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 786 | 0.090 |
Why?
|
| Bayes Theorem | 2 | 2021 | 282 | 0.090 |
Why?
|
| Male | 7 | 2023 | 61028 | 0.080 |
Why?
|
| Psychometrics | 2 | 2023 | 678 | 0.080 |
Why?
|
| Adult | 4 | 2023 | 29397 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1619 | 0.070 |
Why?
|
| Parents | 2 | 2023 | 1039 | 0.070 |
Why?
|
| Mutation | 1 | 2019 | 5809 | 0.060 |
Why?
|
| Family Relations | 1 | 2023 | 68 | 0.050 |
Why?
|
| Confidentiality | 1 | 2023 | 99 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 244 | 0.050 |
Why?
|
| Phenethylamines | 1 | 2021 | 14 | 0.050 |
Why?
|
| Suicidal Ideation | 1 | 2023 | 219 | 0.040 |
Why?
|
| Random Allocation | 1 | 2021 | 436 | 0.040 |
Why?
|
| Animals | 1 | 2022 | 34145 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2022 | 359 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2022 | 152 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2023 | 458 | 0.040 |
Why?
|
| Syndrome | 1 | 2022 | 1124 | 0.040 |
Why?
|
| Pyridines | 1 | 2021 | 229 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 472 | 0.040 |
Why?
|
| Mental Status Schedule | 1 | 2018 | 44 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2022 | 16233 | 0.040 |
Why?
|
| Creatine | 1 | 2018 | 41 | 0.040 |
Why?
|
| Gray Matter | 1 | 2018 | 32 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 507 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 605 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 1099 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 290 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6470 | 0.030 |
Why?
|
| White Matter | 1 | 2018 | 180 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 821 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 580 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1596 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1102 | 0.030 |
Why?
|
| Oxygen | 1 | 2018 | 554 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2018 | 556 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2018 | 824 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 2031 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1892 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2019 | 1061 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 26460 | 0.020 |
Why?
|
| Aged | 2 | 2018 | 19479 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 10149 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6089 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3578 | 0.020 |
Why?
|